Singapore Paincare Holdings Limited (SGX:FRQ)
Singapore · Delayed Price · Currency is SGD 0.0650
0.00 (0.00%)
At close: Sep 7, 2026
SGXC:FRQ Income Statement
Financials in millions SGD. Fiscal year is July - June.
Millions SGD. Fiscal year is Jul - Jun.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Operating Revenue | 27.38 | 25.97 | 26.91 | 22.08 | 18.84 |
Other Revenue | 0.76 | 1.06 | 0.58 | 0.34 | 0.35 |
| 28.14 | 27.03 | 27.49 | 22.42 | 19.19 | |
Revenue Growth | 4.08% | -1.65% | 22.58% | 16.85% | 69.05% |
Cost of Revenue | 20.37 | 18.75 | 17.87 | 13.56 | 10.39 |
Gross Profit | 7.77 | 8.28 | 9.62 | 8.86 | 8.8 |
Selling, General & Admin | 0.24 | 0.43 | 0.24 | 0.21 | 1.25 |
Other Operating Expenses | 3.57 | 4.28 | 4.04 | 4.67 | 1.02 |
Operating Expenses | 6.31 | 7.28 | 6.78 | 6.76 | 3.41 |
Operating Income | 1.46 | 1 | 2.84 | 2.1 | 5.39 |
Interest Expense | -0.34 | -0.27 | -0.26 | -0.21 | -0.15 |
Interest & Investment Income | 0 | 0 | 0 | 0 | 0 |
Earnings From Equity Investments | 0.26 | -0.64 | 0.81 | 0.1 | 0.4 |
Other Non Operating Income (Expenses) | - | -0.22 | -0.24 | - | 0.63 |
EBT Excluding Unusual Items | 1.38 | -0.12 | 3.15 | 1.99 | 6.28 |
Impairment of Goodwill | -1.11 | -2.66 | - | - | - |
Gain (Loss) on Sale of Investments | -0.29 | -0.29 | - | -0.73 | -1.11 |
Gain (Loss) on Sale of Assets | - | 0.02 | - | - | - |
Asset Writedown | - | -0.61 | -0.2 | - | - |
Other Unusual Items | - | - | - | - | 0.04 |
Pretax Income | -0.01 | -3.66 | 2.95 | 1.26 | 5.21 |
Income Tax Expense | -0.06 | 0.08 | 0.58 | 1.29 | 0.88 |
Earnings From Continuing Operations | 0.04 | -3.74 | 2.38 | -0.03 | 4.33 |
Minority Interest in Earnings | -0.9 | -0.3 | -0.41 | -0.64 | -0.43 |
Net Income | -0.86 | -4.03 | 1.97 | -0.67 | 3.9 |
Net Income to Common | -0.86 | -4.03 | 1.97 | -0.67 | 3.9 |
Net Income Growth | - | - | - | - | 77.33% |
Shares Outstanding (Basic) | 171 | 171 | 171 | 175 | 180 |
Shares Outstanding (Diluted) | 171 | 171 | 171 | 175 | 180 |
Shares Change | - | - | -2.31% | -2.55% | 6.01% |
EPS (Basic) | -0.01 | -0.02 | 0.01 | -0.00 | 0.02 |
EPS (Diluted) | -0.01 | -0.02 | 0.01 | -0.00 | 0.02 |
EPS Growth | - | - | - | - | 67.15% |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Free Cash Flow | 4.17 | 1.99 | 2.94 | 3.68 | 5.9 |
Free Cash Flow Per Share | 0.02 | 0.01 | 0.02 | 0.02 | 0.03 |
Dividend Per Share | - | - | - | 0.004 | 0.012 |
Dividend Growth | - | - | - | -70.83% | 60.00% |
Gross Margin | 27.60% | 30.63% | 35.00% | 39.53% | 45.85% |
Operating Margin | 5.17% | 3.71% | 10.34% | 9.38% | 28.09% |
Profit Margin | -3.05% | -14.92% | 7.15% | -2.97% | 20.33% |
Free Cash Flow Margin | 14.81% | 7.34% | 10.70% | 16.43% | 30.75% |
EBITDA | 1.71 | 1.44 | 3.38 | 2.46 | 5.57 |
EBITDA Margin | 6.09% | 5.34% | 12.31% | 10.98% | 29.03% |
D&A For EBITDA | 0.26 | 0.44 | 0.54 | 0.36 | 0.18 |
EBIT | 1.46 | 1 | 2.84 | 2.1 | 5.39 |
EBIT Margin | 5.17% | 3.71% | 10.34% | 9.38% | 28.09% |
Effective Tax Rate | - | - | 19.48% | 102.39% | 16.95% |
Advertising Expenses | 0.02 | - | - | 0.03 | 1.11 |